Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,863.95
12.1 (0.42%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 24.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.42%
0.76%
1W
0.94%
0.1%
1M
-1.23%
-3.46%
YTD
15.9%
-12.16%
1Y
4.6%
-9.4%
3Y
84.31%
13.03%
5Y
90.23%
26.87%
10Y
103.67%
162.59%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
22.77%
0%
22.77%
6 Months
20.29%
2.46%
22.75%
1 Year
4.6%
2.13%
6.73%
2 Years
5.64%
2.52%
8.16%
3 Years
84.31%
6.55%
90.86%
4 Years
102.24%
9.60%
111.84%
5 Years
90.23%
13.09%
103.32%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
16.36%
4
Quartile
quartile-4
Mar-Jun
7.34%
3
Quartile
quartile-3
Dec-Mar
-7.59%
4
Quartile
quartile-4
YTD
4.16%
1
Quartile
quartile-1
2025
9.72%
4
Quartile
quartile-4
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
16.36%
4
Quartile
quartile-4
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
4.16%
1
Quartile
quartile-1
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

1
Quartile
quartile-1
QTD
16.36%
3
Quartile
quartile-3
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
2
Quartile
quartile-2
YTD
4.16%
2
Quartile
quartile-2
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available